MedTrace Logo

Vantas Implant Retrieval Study

NCT01013025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2024-01-02

No results posted yet for this study

Summary

The main study objective was to collect implant retrieval information in 10 patients using Vantas®, the 50 mg histrelin implant. Patients who had been identified as having a difficult to locate or non-palpable implant were to have been enrolled. Sites were to adhere to the instructions in the Package Insert, which included specialized investigations such as ultrasound, CT, and MRI, to be used for the location and removal of implants.

Conditions

Interventions

PROCEDURE

Ultrasound or CT or MRI to locate implant

Scanning methods (eg, ultrasound, CT, or MRI) were used to locate the implant.

Sponsors & Collaborators

  • Endo Pharmaceuticals

    lead INDUSTRY

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-06-30
Completion
2007-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01013025 on ClinicalTrials.gov